Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy U Lin

Showing results (71-80 of 330) with videos related to

Pageof 33
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast CancerAntonio Di Meglio, Nancy U Lin, Rachel A Freedman, et al.
Annals of Surgical Oncology|August 27, 2015
Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer CenterMehra Golshan, Katya Losk, Melissa A Mallory, et al.
Blood|October 22, 2003
Fatal hepatic necrosis following imatinib mesylate therapyNancy U Lin, Stefanie Sarantopoulos, James R Stone, et al.
Cancer Treatment Reviews|January 25, 2022
Global challenges and policy solutions in breast cancer controlDario Trapani, Ophira Ginsburg, Temidayo Fadelu, et al.
Clinical Breast Cancer|January 29, 2025
Factors Associated With Short- and Long-Term Survival in Metastatic HER2-Positive Breast CancerJosé P Leone, Ruth Moges, Julieta Leone, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|March 16, 2007
Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancerElizabeth Bullitt, Nancy U Lin, Matthew G Ewend, et al.
Breast (Edinburgh, Scotland)|January 29, 2013
Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab eraErin M Olson, Julie S Najita, Jessica Sohl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2021
Reply to J. Wei et alNancy U Lin, Mark Pegram, Solmaz Sahebjam, et al.
NPJ Breast Cancer|November 30, 2021
Integrative multiomics-histopathology analysis for breast cancer classificationYasha Ektefaie, William Yuan, Deborah A Dillon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II StudyNancy U Lin, Mark Pegram, Solmaz Sahebjam, et al.
Pageof 33

Showing results (71-80 of 330) with videos related to

Sort By:
Pageof 33
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast CancerAntonio Di Meglio, Nancy U Lin, Rachel A Freedman, et al.
Annals of Surgical Oncology|August 27, 2015
Variation in Additional Breast Imaging Orders and Impact on Surgical Wait Times at a Comprehensive Cancer CenterMehra Golshan, Katya Losk, Melissa A Mallory, et al.
Blood|October 22, 2003
Fatal hepatic necrosis following imatinib mesylate therapyNancy U Lin, Stefanie Sarantopoulos, James R Stone, et al.
Cancer Treatment Reviews|January 25, 2022
Global challenges and policy solutions in breast cancer controlDario Trapani, Ophira Ginsburg, Temidayo Fadelu, et al.
Clinical Breast Cancer|January 29, 2025
Factors Associated With Short- and Long-Term Survival in Metastatic HER2-Positive Breast CancerJosé P Leone, Ruth Moges, Julieta Leone, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|March 16, 2007
Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancerElizabeth Bullitt, Nancy U Lin, Matthew G Ewend, et al.
Breast (Edinburgh, Scotland)|January 29, 2013
Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab eraErin M Olson, Julie S Najita, Jessica Sohl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2021
Reply to J. Wei et alNancy U Lin, Mark Pegram, Solmaz Sahebjam, et al.
NPJ Breast Cancer|November 30, 2021
Integrative multiomics-histopathology analysis for breast cancer classificationYasha Ektefaie, William Yuan, Deborah A Dillon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II StudyNancy U Lin, Mark Pegram, Solmaz Sahebjam, et al.
Pageof 33